These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 7605351

  • 21. Acute effects of moclobemide and deprenyl on 5-HT synthesis rates in the rat brain: An autoradiographic study.
    Nishi K, Mück-Seler D, Hasegawa S, Watanabe A, Diksic M.
    Brain Res Bull; 2006 Oct 16; 70(4-6):368-77. PubMed ID: 17027772
    [Abstract] [Full Text] [Related]

  • 22. L-deprenyl (selegiline) limits the repetitive firing of action potentials in rat hippocampal CA1 neurons via a dopaminergic mechanism.
    Huang CC, Tsai JJ, Hsu KS.
    Brain Res; 1997 Apr 04; 753(1):27-35. PubMed ID: 9125428
    [Abstract] [Full Text] [Related]

  • 23. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A, D'Agostini F, Cesura AM, Borroni E, Da Prada M.
    J Pharmacol Exp Ther; 1993 Apr 04; 265(1):103-11. PubMed ID: 8473998
    [Abstract] [Full Text] [Related]

  • 24. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1991 Jan 04; 55(1):121-8. PubMed ID: 1904113
    [Abstract] [Full Text] [Related]

  • 25. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
    Braestrup C, Andersen H, Randrup A.
    Eur J Pharmacol; 1975 Nov 04; 34(1):181-7. PubMed ID: 1241962
    [Abstract] [Full Text] [Related]

  • 26. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I, Ross SB.
    J Neurochem; 1986 Aug 04; 47(2):569-76. PubMed ID: 3734795
    [Abstract] [Full Text] [Related]

  • 27. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 04; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 28. Deprenyl stimulates the efflux of monoamines from the rat hypothalamus in vitro.
    MohanKumar PS, MohanKumar SM, Quadri SK.
    Brain Res Bull; 2001 Apr 04; 54(6):675-80. PubMed ID: 11403995
    [Abstract] [Full Text] [Related]

  • 29. [3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B.
    Cesura AM, Galva MD, Imhof R, Kyburz E, Picotti GB, Da Prada M.
    Eur J Pharmacol; 1989 Mar 29; 162(3):457-65. PubMed ID: 2744079
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JA.
    Br J Pharmacol; 1997 Jul 29; 121(5):901-12. PubMed ID: 9222546
    [Abstract] [Full Text] [Related]

  • 33. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP.
    Neuropeptides; 1993 Jul 29; 25(1):35-45. PubMed ID: 7692341
    [Abstract] [Full Text] [Related]

  • 34. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.
    Saura J, Kettler R, Da Prada M, Richards JG.
    J Neurosci; 1992 May 29; 12(5):1977-99. PubMed ID: 1578281
    [Abstract] [Full Text] [Related]

  • 35. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y.
    Hokkaido Igaku Zasshi; 2001 May 29; 76(3):133-42. PubMed ID: 11481866
    [Abstract] [Full Text] [Related]

  • 36. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L.
    Br J Pharmacol; 1986 Aug 29; 88(4):827-35. PubMed ID: 3091132
    [Abstract] [Full Text] [Related]

  • 37. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V, Pycock CJ, Sandler M.
    Br J Pharmacol; 1983 Sep 29; 80(1):141-8. PubMed ID: 6418254
    [Abstract] [Full Text] [Related]

  • 38. Pharmacodynamics of lazabemide, a reversible and selective inhibitor of monoamine oxidase B.
    Holford NH, Guentert TW, Dingemanse J, Kettler R.
    Br J Clin Pharmacol; 1994 Jun 29; 37(6):553-7. PubMed ID: 7917773
    [Abstract] [Full Text] [Related]

  • 39. Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex.
    Guimarães JT, Vindis C, Soares-da-Silva P, Parini A.
    Life Sci; 2003 Jul 11; 73(8):955-67. PubMed ID: 12818349
    [Abstract] [Full Text] [Related]

  • 40. Investigation of the presynaptic effects of quinine and quinidine on the release and uptake of monoamines in rat brain tissue.
    Clement EM, Grahame-Smith DG, Elliott JM.
    Neuropharmacology; 1998 Jul 11; 37(7):945-51. PubMed ID: 9776390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.